DEBT (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 07, 2025 |
Sep. 03, 2025 |
Aug. 22, 2025 |
Aug. 31, 2023 |
Oct. 31, 2017 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 30, 2024 |
Sep. 30, 2024 |
Apr. 01, 2024 |
Mar. 31, 2024 |
Aug. 30, 2023 |
|
| Debt Instrument [Line Items] | ||||||||||||
| Lline of credit | ||||||||||||
| Line of credit facility, commitment fee amount | 44,000 | |||||||||||
| Line of credit, remaining borrowing base | $ 10,000,000.0 | |||||||||||
| Fair Value, Concentration of Risk, Cash and Cash Equivalents | $ 1,100,000 | $ 119,000 | ||||||||||
| Vehicle Financing Notes [Member] | Minimum [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Term | 3 years | |||||||||||
| Vehicle Financing Notes [Member] | Maximum [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Term | 6 years | |||||||||||
| Provident Bank [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Line of credit, maximum borrowing capacity | $ 10,000,000 | |||||||||||
| Debt instrument description | The facility is secured by, among other things, a first lien security interest in substantially all of the domestic assets and other property of the Company. The interest rate of the facility is an adjustable rate equal to the margin (300 basis points) over an independent index which is equal to the Secured Overnight Financing Rate (“SOFR”). The cost of the Provident line of credit, which is included in interest expense, is approximately $116,000 for the year ended December 31, 2025. The Agreement contains various covenants and conditions governing the revolving line of credit including an initial commitment fee of $35,000 and an annual fee of $35,000 thereafter. At December 31, 2025, the Company was in compliance with all covenants | |||||||||||
| Line of credit, current borrowing capacity | $ 8,300,000 | |||||||||||
| Medsphere Systems Corporation [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Business combination Acquisition | On August 22, 2025, the Company entered into a Deferred Payment Agreement with Wells Fargo for $8,250,000 pursuant to the Purchase Agreement with Medsphere. The Deferred Payment Agreement had an interest rate of 12% per year with a maturity date of February 20, 2026 and was secured by substantially all of the Company’s assets. The Deferred Payment Agreement was paid on September 3, 2025 | |||||||||||
| Five Year Loan Agreement [Member] | Republic Bank And Trust Company [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Purchase of aircraft | $ 1,032,000 | |||||||||||
| Interest rate for loan | 6.75 | |||||||||||
| SVB Credit Facility [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Line of Credit Facility, Covenant Terms | The SVB credit facility was secured revolving line of credit where borrowings were based on a formula of 200% of repeatable revenue adjusted by an annualized attrition rate as defined in the credit agreement | |||||||||||
| Line of Credit Facility, Interest Rate at Period End | 2.00% | 1.50% | 2.00% | 1.50% | ||||||||
| Minimum liquidity ratio reduction amendments expiry date | Mar. 31, 2024 | |||||||||||
| Line of credit, description | There was also a fee of one-half of 1% annually for the unused portion of the credit line | |||||||||||
| Percentage of shares in off shore facilities | 65.00% | |||||||||||
| SVB Credit Facility [Member] | Ninth Loan Modification Agreement [Member] | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Line of credit, maximum borrowing capacity | $ 10,000,000 | $ 25,000,000 | ||||||||||